SCHEMBL6489142

SCHEMBL6489142

Cc1cc(OCc2ccccc2C(=O)O)cc2c1nc(C)n2Cc1ccc(C#N)cc1F

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GLP1R P43220 9/20 0.42
BCL2 P10415 6/20 0.41
MCL1 Q07820 6/20 0.41
KCNH2 Q12809 3/20 0.40
PDE10A Q9Y233 1/20 0.40
ALOX5AP P20292 1/20 0.39
HTR1A P08908 1/20 0.38
CYP2C8 P10632 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6492596 0.92 GLP1R (0.39) GLP1RBCL2MCL1KCNH2PDE10A
SCHEMBL7195498 0.90 GLP1R (0.41) GLP1RKCNH2PDE10AALOX5APHTR1A
SCHEMBL6500839 0.90 BCL2 (0.45) BCL2MCL1
SCHEMBL6490402 0.86 MRGPRX4 (0.48) GLP1RBCL2MCL1ALOX5AP
SCHEMBL6501511 0.82 BCL2 (0.38) BCL2MCL1
SCHEMBL7203763 0.81 PIK3C2B (0.41) GLP1RBCL2MCL1ALOX5AP
SCHEMBL6500552 0.80 MRGPRX4 (0.49) BCL2MCL1ALOX5AP
SCHEMBL6489585 0.80 BCL2 (0.48) BCL2MCL1
SCHEMBL6501134 0.79 BCL2 (0.47) BCL2MCL1
SCHEMBL6499333 0.78 BCL2 (0.50) BCL2MCL1ALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD GLP1R 144/4885BCL2 774/4885MCL1 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.